Advancing Intelligent Pressure Ulcer Prevention

About
Quelofy Technologies Private Limited is a medtech/healthtech startup committed to redefining patient safety and quality of care through innovative pressure ulcer prevention technologies.

The company’s flagship focus is Preventix, a next-generation platform designed to deliver end-to-end monitoring and prevention of pressure ulcers (bed sores). Preventix is purpose-built for use in hospitals, elderly care homes, rehabilitation centers, and long-term care settings where patients are at high risk of immobility-related complications.

Founded and led by Manoj and Keerthana, Quelofy is driven by a vision to create affordable, intuitive healthcare solutions that equip patients, caregivers, and clinicians with timely, actionable insights. By enabling early intervention, Quelofy aims to prevent serious complications such as tissue damage, infections, and sepsis—ultimately saving lives and improving outcomes.

With Preventix, Quelofy aims to:

• Identify pressure-related risk and skin stress in real time

• Provide early alerts to caregivers and clinicians before ulcers develop or worsen

• Minimize reliance on rigid manual turning schedules through data-driven positioning recommendations

• Enable proactive, intelligent pressure ulcer prevention strategies

• Enhance patient comfort while improving clinical outcomes across care environments

• Make advanced prevention technology accessible and affordable throughout India

Company Details

Founders: Manoj and Keerthana
Date of Incorporation: October 15, 2025
Registered Office: No. 171, OM Sai Nagar, Kalluballu, Jigani, Bangalore, Karnataka – 560105
Website: www.quelofy.com

Whether you are a hospital working to reduce hospital-acquired pressure ulcers, a long-term care facility focused on improving resident well-being, a rehabilitation center managing complex recovery needs, or a healthcare professional seeking smarter prevention tools, Quelofy Technologies offers solutions designed to make a measurable impact.

Quelofy is not merely building a product—it is reshaping the standard of care for some of the most vulnerable patient populations. The future of pressure ulcer prevention is intelligent, proactive, data-driven, and patient-centric.
That future is Preventix.